SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull (BULL) is trending after reporting strong Q4 and full-year revenue and customer asset growth, despite an EPS miss attributed to increased growth investments. Community sentiment is deeply divided, with many citing deep undervaluation and significant institutional buying, while others criticize management for sustained price declines and concerns over dilution.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is surging on reports of a groundbreaking partnership with Novo Nordisk to sell obesity drugs, ending a prior feud. This unexpected alliance, announced late Friday, has fueled immense speculation about a massive short squeeze, leaving a highly shorted float vulnerable and sparking widespread bullish sentiment.

SHP ETF Trust - FIS Biblically Responsible Risk Managed ETF

The $PRAY ETF is trending as widespread community discussion centers on the intersection of faith, biblical principles, and financial decision-making, directly reflecting its "Biblically Responsible" investment strategy. Users are engaging in conversations about ethical investing, seeking divine guidance in wealth management, and debating the morality of various market practices.

Rich Sparkle Holdings Ltd. engages in the provision of financial printing and corporate services. The firm offers typesetting, proofreading, translation, design, and printing of listing documents, financial reports, fund documents, circulars, and announcements. It also delivers advisory services, such as conducting internal control assessment and environmental, social and governance performance evaluation, and other services including provision of co-working space. The company was founded in 2016 and is headquartered in Hong Kong.

Rich Sparkle Holdings Ltd.

Rich Sparkle Holdings Limited

Rich Sparkle Holdings (ANPA) is seeing significant action after its acquisition of TikTok icon Khaby Lame's core company, sparking intense speculative interest due to its low float and high insider ownership, as traders weigh massive short squeeze potential against sharp warnings of a pump-and-dump.

ViaSat, Inc. engages in providing communications technologies and services. It operates through the Communication Services and Defense and Advanced Technologies business segments. The Communication Services business segment provides a wide range of broadband and narrowband communications solutions across government and commercial mobility markets. The Defense and Advanced Technologies business segment develops and offers a diverse array of resilient, vertically integrated solutions to government and commercial customers, leveraging the company’s technical competencies in encryption, cyber security, tactical gateways, modems, and waveforms. The company was founded by Mark D. Dankberg and Mark J. Miller on May 1, 1986 and is headquartered in Carlsbad, CA.

Viasat, Inc.

Viasat is trending following a Deutsche Bank upgrade, recent earnings strength in its government and aviation segments, and the anticipation surrounding its Viasat-3 F2/F3 satellite deployments. The community is actively discussing the potential spin-off of its defense unit, which many believe could unlock significant shareholder value given its established infrastructure and key government certifications in the expanding satellite communications sector.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MSTR is a central topic as a leveraged proxy for Bitcoin, with community members actively debating the impact of strong institutional ETF inflows and Bitcoin's recent resilience, while others caution about dilution and potential market pullbacks.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is experiencing a significant surge as the escalating Middle East conflict effectively disrupts shipping in the Strait of Hormuz, driving fears of prolonged oil supply shortages. The community is sharply divided, with many anticipating crude prices to climb much higher while others predict an imminent correction fueled by potential US intervention to stabilize the market.

Venture Global, Inc. engages in the development and construction of liquefied natural gas production, establishing us as a rapidly growing company delivering critical LNG to the world. It projects include Calcasieu, Plaquemines, CP2, CP3 and Delta projects. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global ($VG) is trending amidst global energy market turmoil, as Middle East disruptions, including Qatar's LNG production halt and Strait of Hormuz shipping concerns, create a significant supply deficit. The community is actively discussing VG's strategic position as a U.S.-based exporter with substantial uncontracted capacity, poised to capture high spot prices and benefit from increased demand, further strengthened by a recent favorable arbitration ruling.

Monad is a high-performance Layer 1 blockchain that processes 10,000 transactions per second with near-zero fees. The platform delivers high performance without compromising on security or decentralization, creating the infrastructure needed for complex applications that require high-frequency activity.  One of Monad’s key innovations lies in how it handles transaction processing. Instead of processing transactions one at a time like traditional blockchains, Monad processes multiple transactions simultaneously through parallel execution.   The system separates the agreement process from the execution process, allowing validators to first agree on which transactions to include and in what order, then having more time to execute those transactions without slowing down consensus. This approach, combined with a custom-built database called MonadDB, dramatically increases throughput while maintaining accuracy.  Monad also offers complete EVM compatibility, where applications built for Ethereum work on Monad without any code modifications, and users can connect with familiar wallets like MetaMask just as they would on Ethereum. Developers can immediately tap into Ethereum's established ecosystem of tools, libraries, and applications while benefitting from Monad’s performance improvements. The platform also runs on consumer-grade hardware rather than expensive specialized equipment, making it accessible for more people to participate in securing the network.  Monad has raised approximately 244 million dollars in total funding across multiple rounds. The company secured 19 million dollars in a seed round in February 2023 led by Dragonfly Capital, followed by a 225 million dollar Series A round in April 2024 led by Paradigm at a 3 billion dollar valuation. Other notable investors include Electric Capital, Greenoaks, Coinbase Ventures, and prominent angel investors such as Naval Ravikant.

Monad

Monad (MON) is gaining significant attention as its innovative Layer 1 blockchain sees new DeFi integrations and a rapidly expanding user base, fueling community discussions about its potential to rival existing chains and its attractive staking yields. Many investors are accumulating, viewing its current valuation as an early entry point for substantial long-term value.

Vanguard Index Funds - Vanguard S&P 500 ETF

Vanguard S&P 500 ETF

The Vanguard S&P 500 ETF (VOO) is a trending topic amidst heightened geopolitical tensions and economic uncertainty, as investors assess inflation data and Fed policy. Despite calls for a market correction, many in the community continue to champion VOO for long-term passive investing and dollar-cost averaging, reflecting significant sustained ETF inflows.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

GW&K Investment Management LLC Sells 17,849 Shares of Jazz Pharmaceuticals PLC $JAZZ

GW&K Investment Management LLC cut its holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ - Free Report) by 3.8% during the third quarter, according to the company in its most recent 13F filing with...

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Given Consensus Rating of "Moderate Buy" by Brokerages

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the seventeen analysts that are covering the firm, MarketBeat.com reports. One...

Jazz Pharmaceuticals (NASDAQ:JAZZ) Director Sells 3,415 Shares

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ - Get Free Report) Director Norbert Riedel sold 3,415 shares of the business's stock in a transaction on Friday, February 27th. The stock was sold at an average...

Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034)  DelveInsight

Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight Biliary Tract Cancer Market is Predicted to Exhibit...

Jazz Pharmaceuticals (NASDAQ:JAZZ) CAO Patricia Carr Sells 1,117 Shares

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ - Get Free Report) CAO Patricia Carr sold 1,117 shares of Jazz Pharmaceuticals stock in a transaction on Friday, February 27th. The stock was sold at an average...

Patricia Carr Sells 1,253 Shares of Jazz Pharmaceuticals (NASDAQ:JAZZ) Stock

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ - Get Free Report) CAO Patricia Carr sold 1,253 shares of Jazz Pharmaceuticals stock in a transaction dated Thursday, February 26th. The stock was sold at an...

Insider Selling: Jazz Pharmaceuticals (NASDAQ:JAZZ) SVP Sells 5,343 Shares of Stock

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ - Get Free Report) SVP Mary Elizabeth Henderson sold 5,343 shares of the stock in a transaction that occurred on Thursday, February 26th. The stock was sold at...

Jazz Pharmaceuticals (NASDAQ:JAZZ) EVP Neena Patil Sells 55,600 Shares

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ - Get Free Report) EVP Neena Patil sold 55,600 shares of the firm's stock in a transaction on Thursday, February 26th. The stock was sold at an average price of...

Jazz (JAZZ) Reliance on International Sales: What Investors Need to Know

Examine Jazz's (JAZZ) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.

This Jazz Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday

Top analysts changed outlook on top names. Check analyst ratings page for upgrades, downgrades, initiations. See what they think of JAZZ stock.read more...

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

JAZZ
Jazz Pharmaceuticals plc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest JAZZ News

JAZZJazz Pharmaceuticals plc